RepliCel in the News

April 30, 2013

June 11, 2012 – Vancouver, British Columbia – RepliCel Life Sciences Inc. (the “Company” or “RepliCel”) (OTCBB:REPCF) presented significant new data from its Phase I/IIa first-in-man clinical trial at its Annual General Meeting (“AGM”) of Shareholders held on Monday, June 11, 2012. To view a copy of the presentation, please click here. David Hall, RepliCel’s ... Continue reading →

July 5, 2012

(English Translation) Injected hair stem cells are emerging as the most effective therapy against baldness
 EFE News Barcelona, June 22 (EFE). Canadian scientists have been able to grow hair in bald individuals through implantation of hair stem cells, a pioneering therapy that experts predict will be most effective against this phenomenon that affects a significant ... Continue reading →

(English Translation) HAZTEOIR.ORG 
The website of the active citizen
 June 22, 2012 

 The patient’s own stem cells are seen as most effective way to treat alopecia 
 

 

Introduced in Europe, at a convention in Barcelona, the results of research carried out by the team of Dr. Kevin McElwee, University of British Columbia in ... Continue reading →

February 7, 2012

AskMen.com Men And Balding By Jeremy Berger, February 6, 2012 The plague that has dogged us for centuries may finally be vanquished. Balding is the hoverboard of medical research. If someone had told me in 1989 that, more than 20 years later, my Birdhouse deck wouldn’t float, I’d have told the butthead to get lost. ... Continue reading →

November 22, 2011

Effective treatment for hair loss has advanced considerably over the past several decades, but for all that the multi-billion dollar industry has become, there still lacks a truly viable and permanent solution that addresses the needs of both men and women. For biotech company RepliCel Life Sciences, Inc. (REPCF), promising research around the regenerative properties ... Continue reading →